A comprehensive view of Oral Medicines / Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pet Care Market Intelligence Service.
INTERNATIONAL PATENT: SIEMENS HEALTHCARE DIAGNOSTICS INC. FILES APPLICATION FOR "METHOD AND DEVICE FOR DETERMINING ONSET OF SEPSIS IN EMERGENCY SET-UPS"
Published:
May 15, 2024
by U.S. Fed News
|
Pfizer launches Phase 1 clinical trial to evaluate oral PF-07293893 on skeletal muscle biomarkers in 60 healthy adult participants in the US; the drug is being studied as possible treatment for heart disease
Published:
May 15, 2024
by Contify Life Science News
|
INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "ORAL FORMULATION OF N-PYRIDINYL ACETAMIDE DERIVATIVE FOR TREATING INTERSTITIAL LUNG DISEASE"
Published:
May 14, 2024
by U.S. Fed News
|
Cipla recalls 59,244 packs of Ipratropium Bromide and Albuterol Sulfate inhalation solution, Glenmark recalls 3,264 bottles of Diltiazem Hydrochloride extended-release capsules; Lupin recalls 26,352 bottles of Rifampin capsules
Published:
May 07, 2024
by Indian Technology News
|
Biopharmaceutical firm Alkermes concludes the sale of its development and manufacturing facility in Athlone, Ireland, to Novo Nordisk for US$91.0M; the plant provides Novo Nordisk with additional development and manufacturing capacity for oral products
Published:
May 06, 2024
by Marketline - Deals
|
Ask us about our Pet Care market view